1418205-77-2
1418205-77-2
Chemical Structure
Bimekizumab
Synonym(s): CDP4940; UCB-4940
- CAS No.: 1418205-77-2
- Formula:N/A
- Molecular Weight:(147.24 kDa)
IUPAC Name: 1-(6-bromopyridin-2-yl)azetidine-3-carboxylic acid
SMILES: [Bimekizumab]
Biological Activity: Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bimekizumab | 99.44% | Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
